Conflates lab economics, app-layer economics, and customer ROI: different answers each.
Held by lab CFOs, growth investors
Inference cost/token has fallen orders of magnitude; serving gross margins positive and improving; losses are training capex and S-curve acquisition. Revenue growing faster than prior software categories.
Strongest opposing: Q3-S3B
Evidence behind its claims: 328 support · 69 contradict · 301 neutral
Held by skeptical software analysts, VCs who passed
Headline margins exclude the cost of the model rebuilt every 12–18 months; 'cost/token falling' is true but irrelevant if you must keep spending more to reset the clock. Revenue per dollar of compute is poor.
Strongest opposing: Q3-S3A
Evidence behind its claims: 218 support · 45 contradict · 194 neutral
Held by app-layer founders, enterprise SaaS investors
Bear version: labs commoditize apps from below. Bull version: workflow integration + proprietary data create defensible margin above the model.
Evidence behind its claims: 93 support · 51 contradict · 143 neutral
3.1 · Inference cost per unit of capability is falling rapidly.
3.2 · Frontier training costs rise fast enough to outpace per-model revenue.
3.3 · Enterprises achieve measurable ROI and renew / expand, not just pilot.
3.4 · App-layer companies retain margin after the model commoditizes their feature.
3.5 · Recognized revenue (not bookings / ARR run-rate) grows at claimed rates.
3.6 · Training-data IP liability is now a quantifiable balance-sheet cost for AI vendors, and vendors unable to document clean training-data provenance face incremental procurement exclusion risk in enterprise and government channels.